Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: The Postmenopausal Estrogen/Progestins Interventions (PEPI) Trial

Journal of Clinical Epidemiology

Volumn 52, Issue 12, 1999, Pages 1187-1195

  Legault, Claudine ^a   Stefanick, Marcia L ^b   Miller, Valery T ^c   Marcovina, Santica M ^d   Schrott, Helmut G ^e  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

Friedewald; Hormone replacement therapy; LDL C; Lipids; Lipoproteins; Postmenopause

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MODEL; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ALGORITHMS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DRUG THERAPY, COMBINATION; ESTROGENS, CONJUGATED (USP); FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE; PROGESTERONE CONGENERS; PROGESTINS; REPRODUCIBILITY OF RESULTS; TRIGLYCERIDES;

EID: 0032694496     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(99)00107-9     Document Type: Article

References (27)

1. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
2. Niedbala R.S., Schray K.J., Foery R., Clement G. Estimation of low-density lipoprotein by the Friedewald formula and by electrophoresis compared [letter]. Clin Chem. 31:1985;1762-1763.
3. Demacker P.N., Hijmans A.G., Brenninkmeijer B.J.et al. Five methods for determining low-density lipoprotein cholesterol compared. Clin Chem. 30:1984;1797-1800.
4. Myers L.H., Phillips N.R., Havel R.J. Mathematical evaluation of methods for estimation of the concentration of the major lipid components of human serum lipoproteins. J Lab Clin Med. 88:1976;491-505.
5. Kuba K., Frantz I.D. Validity of the Friedewald equation for the estimation of plasma low-density lipoprotein cholesterol (LDL-C) at various concentrations of triglycerides [abstract]. Clin Chem. 33:1987;896.
6. Wilson P.W., Abbott R.D., Garrison R.J., Castelli W.P. Estimation of very-low-density lipoprotein cholesterol from data on triglyceride concentration in plasma. Clin Chem. 27:1981;2008-2010.
7. Rao A., Parker A.H., El-Sheroni N.A., Babelly M.M. Calculation of low-density lipoprotein cholesterol with use of triglyceride/cholesterol ratios in lipoproteins compared with other calculation methods. Clin Chem. 34:1988;2532-2534.
8. Lippi U., Graziani M.S., Manzato F., Schinella M. The Friedewald formula. Statistical acrobatics? Clin Chem. 32:1986;909-910.
9. Warnick G.R., Knopp R.H., Fitzpatrick V., Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem. 36:1990;15-19.
10. DeLong D.M., DeLong E.R., Wood P.D., Lippel K., Rifkind B.M. A comparison of methods for the estimation of plasma low-and very-low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study JAMA. 256:1986;2372-2377.
11. Friedlander Y., Kark J.D., Eisenberg S., Stein Y. Calculation of LDL-cholesterol from total cholesterol, triglyceride and HDL-cholesterol. A comparison of methods in the Jerusalem Lipid Research Clinic Prevalence Study Isr J Med Sci. 18:1982;1242-1252.
12. Winocour P.H., Ishola M., Durrington P.N. Validation of the Friedewald formula for the measurement of low density lipoprotein cholesterol in insulin-dependent diabetes mellitus. Clin Chim Acta. 179:1989;79-84.
13. Fujimoto W.Y. Friedewald's LDL-cholesterol estimation formula in a Japanese American population. Jpn Circ J. 52:1988;604-606.
14. Walsh B.W., Schiff I., Rosner B., Greenberg L., Ravnikar V., Sacks F.M. Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins. N Eng J Med. 325:1991;1196-1204.
15. Muesing R.A., Miller V.T., LaRosa J.C.et al. Effects of unopposed conjugated equine estrogen on lipoprotein composition and apolipoprotein-E distribution. J Clin Endocrinol Metab. 75:1992;1250-1254.
16. Miller V.T., Muesing R.A., LaRosa J.C., Stoy D.B., Fowler S.E., Stillman R.J. Quantitative and qualitative changes in lipids, lipoproteins, apolipoprotein A-I and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin. Obstet Gynecol. 83:1994;173-179.
17. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 273:1995;199-208.
18. Espeland M.A., Bush T.L., Mebane-Sims I.et al. Rationale, design and conduct of the PEPI Trial. Controlled Clin Trials. 16:1995;3S-19S.
19. Wood P.D., Kessler G., Lippel D., Stefanick M.L., Wasilauskas C.H., Wells H.B. Physical and laboratory measurements in the PEPI Trial. Controlled Clin Trials. 16:1995;36S-53S.
20. Warnick G.R. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol. 129:1986;101-123.
21. Hainline A Jr, Karon J, Lippel K, Eds. Manual of Laboratory Operations: Lipid Research Clinics Program, Lipid and Lipoprotein Analysis, 2nd Ed. US Department of Health and Human Services, Public Health Service, National Institutes of Health (Updated 1983).
22. Warnick G.R., Benderson J., Albers J.J. Dextran sulfate-Mg2+ precipitation procedure for quantification of high-density lipoprotein cholesterol. Clin Chem. 28:1982;1279-1288.
23. Miller V.T., Byington R.L., Espeland M.A., Langer R., Marcus R., Shumaker S., Stern M.P. Baseline characteristics of the PEPI participants. Controlled Clin Trials. 16:1995;54S-65S.
24. Wilson P.W.F., Zech L.A., Gregg R.E., Schaefer E.J., Hoeg J.M., Spreder D.L., Brewer H.B. Estimation of VLDL Cholesterol in hyperlipidemia. Clin Chim Acta. 151:1985;285-291.
25. Rifai N., Warnick G.R., McNamara J.R., Belcher J.D., Grinstead G.F., Frantz I.D. Measurement of low-density-lipoprotein cholesterol in serum. A status report Clin Chem. 38:1992;150-160.
26. Wood P.D., Haskel W.L., Stern M.P.et al. Plasma lipoprotein distributions in male and female runners. Ann NY Acad Sci. 301:1977;748-752.
27. Bachorik P.S., Ross J.W. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol. Executive summary. The National Cholesterol Educating Program Working Group on Lipoprotein Measurement Clin Chem. 41(10):1995;1414-1420.